Press Release: Preparing Health Network CEOs for Success with Precision Medicine: Early-Adopter Health Systems to Gather in Nashville September 12-13 to Share Advances in Oncology, Pharmacogenomics, Big Data

PRESS RELEASE

PRECISION MEDICINE INSTITUTE, LLC
21806 Briarcliff Dr.
Spicewood, Texas 78669
512-264-7103 o
512-264-0969 f

FOR IMMEDIATE RELEASE

Media Contact: Chris Garcia
Chris@darkreport.com

AUSTIN, Texas (August 14, 2018)—Precision Medicine is happening now at first-mover hospitals and health systems! September 12-13 in Nashville, experts from the nation’s most successful precision medicine clinical programs will gather to share their strategies and lessons learned. The goal of this conference is to provide hospital CEOs with the insights needed to initiate effective precision medicine programs in their own institutions.

Precision Medicine for Health Network CEOs: What You Need to Know about Genetic Testing, Precision Medicine, and Population Health Management” is a timely, two-day conference. It takes place at the Hutton Hotel in Nashville. This intimate meeting features nationally-respected, first-mover and early-adopter health networks sharing strategies, patient care successes, and outcomes from their precision medicine programs.

Keynote speaker is Jeffrey Balser, MD, the CEO of Vanderbilt University Medical Center. VUMC is internationally recognized for its pioneering efforts to bring precision medicine into daily clinical care. Attendees will gain essential insights into the early successes of precision medicine at VUMC, and will also learn about how the healthcare big database at Vanderbilt is being used to inform population health initiatives while also guiding the care that clinicians deliver daily to individual patients.

Among the twenty expert speakers sharing their respective experiences at bringing precision medicine, genetic medicine, and genetic testing into the daily care provided to their patients, will be:

  • Howard L. McLeod, PharmD, Medical Director, Personalized Medicine Institute, Moffitt Cancer Center, on Precision Medicine in Oncology/Cancer Care
  • Mark Van Oene, Chief Commercial Officer, Illumina, Inc., on Genetic Testing and Gene Sequencing’s Role in Precision Medicine
  • Julie A Johnson, PharmD, Dean, College of Pharmacy, University of Florida, on Precision Medicine in Pharmacogenomics
  • Josh Denny, MD, Vice President of Personalized Medicine at Vanderbilt University Medical Center, on Genetic and Molecular Data in Population Health

For more information and to register to attend “Precision Medicine for Health Network CEOs: What You Need to Know about Genetic Testing, Precision Medicine, and Population Health Management,” click here.  You may also contact Chris Garcia at 512-264-7103.

About Precision Medicine Institute, LLC

The Precision Medicine Institute has the unique mission of bringing together the executive leaders and physician leaders of the nation’s leading healthcare organizations, health networks, and corporations to understand the successes of first-movers and early-adopters as they bring precision medicine into clinical settings. The emphasis is on high-level knowledge of business strategies, clinical initiatives, and operational requirements needed to implement and sustain a clinically-effective and financially-sustainable precision medicine service that measurably improves patient care while helping hospitals avoid costs and generating ample reimbursement.

-end-